U01-4411 and U06- 18160
description
Transcript of U01-4411 and U06- 18160
![Page 1: U01-4411 and U06- 18160](https://reader033.fdocuments.in/reader033/viewer/2022061506/5681451f550346895db1e292/html5/thumbnails/1.jpg)
U01-4411 and U06-18160
#726961800
![Page 2: U01-4411 and U06- 18160](https://reader033.fdocuments.in/reader033/viewer/2022061506/5681451f550346895db1e292/html5/thumbnails/2.jpg)
U01-4411
• 66 y.o. male
• ? Wegener’s
![Page 3: U01-4411 and U06- 18160](https://reader033.fdocuments.in/reader033/viewer/2022061506/5681451f550346895db1e292/html5/thumbnails/3.jpg)
72 yo male. PMhx: prostate CA (radical prostatectomy - deemed curative), COPD. 2001: •Hemoptysis, bilateral pulmonary infiltrates, active urine sediment, sCr=150, pANCA (+). •Renal biopsy: some IgG subepithelial immune complexes consistent with membranous, but 3/14 glomeruli show focal proliferation and necrosis, 1/14 crescent. Dx: WGTx: 1 year of cyclophosphamide and prednisone, then d/c’d.2001-2005•Followed by nephrologist•Clinically quiescent disease, stable sCr: 100-120
![Page 4: U01-4411 and U06- 18160](https://reader033.fdocuments.in/reader033/viewer/2022061506/5681451f550346895db1e292/html5/thumbnails/4.jpg)
IF
• IgG- Mild to moderate coarse capillary loop staining. • IgA- Trivial to trace capillary loop staining. • IgM- Trivial to trace capillary loop staining. • C3- Trivial to trace capillary loop staining. • C1q- Negative.• Kappa- Moderate coarse capillary loop staining. • Lambda- Trivial to trace capillary loop staining. • Fibrin- Negative.• Albumin- Negative.
![Page 5: U01-4411 and U06- 18160](https://reader033.fdocuments.in/reader033/viewer/2022061506/5681451f550346895db1e292/html5/thumbnails/5.jpg)
IgG
![Page 6: U01-4411 and U06- 18160](https://reader033.fdocuments.in/reader033/viewer/2022061506/5681451f550346895db1e292/html5/thumbnails/6.jpg)
Kappa
![Page 7: U01-4411 and U06- 18160](https://reader033.fdocuments.in/reader033/viewer/2022061506/5681451f550346895db1e292/html5/thumbnails/7.jpg)
![Page 8: U01-4411 and U06- 18160](https://reader033.fdocuments.in/reader033/viewer/2022061506/5681451f550346895db1e292/html5/thumbnails/8.jpg)
![Page 9: U01-4411 and U06- 18160](https://reader033.fdocuments.in/reader033/viewer/2022061506/5681451f550346895db1e292/html5/thumbnails/9.jpg)
DiagnosisRenal Biopsy:• Combined membranous glomerulopathy
and focal proliferative necrotizing glomerulonephritis with crescent formation.
• Rule out SLE.
![Page 10: U01-4411 and U06- 18160](https://reader033.fdocuments.in/reader033/viewer/2022061506/5681451f550346895db1e292/html5/thumbnails/10.jpg)
Comment• There have been several reports of such a
combination (Taniguchi, Chronic nephrology 52:253-255, 1991 ; NDT 12:1017-1027, 1997).
• Most of the cases described had systemic lupus.
• Many light microscopic features suggest lupus in our case but IF positivity for only 2 reactants would be distinctly unusual.
![Page 11: U01-4411 and U06- 18160](https://reader033.fdocuments.in/reader033/viewer/2022061506/5681451f550346895db1e292/html5/thumbnails/11.jpg)
Comment
• Our case is intriguing in that fluorescence positivity appears monoclonal or oligoclonal with positive IgG and kappa but negative lambda.
![Page 12: U01-4411 and U06- 18160](https://reader033.fdocuments.in/reader033/viewer/2022061506/5681451f550346895db1e292/html5/thumbnails/12.jpg)
U06-18160
• Rising creatinine
• Pulmonary/renal « syndrome »
• Previous kidney biopsy UAH 5 years ago
![Page 13: U01-4411 and U06- 18160](https://reader033.fdocuments.in/reader033/viewer/2022061506/5681451f550346895db1e292/html5/thumbnails/13.jpg)
January 2006: sCr=133 on routine testing
August 18, 2006: sCr=182, P/C=70 mg/mmol
August 28, 2006. Evaluated by new nephrologist. • Completely asymptomatic, physical exam
significant only for hypertension (180s). • sCr=253 (eGFR=23), active urine. U/S: normal;
CXR: clear• Started on Prednisone 60 mg daily.
![Page 14: U01-4411 and U06- 18160](https://reader033.fdocuments.in/reader033/viewer/2022061506/5681451f550346895db1e292/html5/thumbnails/14.jpg)
Sept 18, 2006: • -Develops ?scant hemoptysis and SOB. bp: 190
systolic, hypoxic requiring 4L O2, CXR: LLL consolidation.
• -Admitted to UAH Pulmonary ward• -Bronchoscopy: NO hemorrhage. • -Blood and BAL culture: Strep pneumoniae. Tx:
Levofloxacin.• -Cr=365, active urine sediment, P/C=260 mg/mmol• -pANCA weakly positive, anti-GBM negative. Aggressively fluid resuscitated
![Page 15: U01-4411 and U06- 18160](https://reader033.fdocuments.in/reader033/viewer/2022061506/5681451f550346895db1e292/html5/thumbnails/15.jpg)
Sept 20, 2006
-sCr=360 (non-oliguric), hypoxia/cough improving.
Transfer to nephrology
Sept 22, 2006: sCr=440 : << RENAL BIOPSY >>
![Page 16: U01-4411 and U06- 18160](https://reader033.fdocuments.in/reader033/viewer/2022061506/5681451f550346895db1e292/html5/thumbnails/16.jpg)
IF
• IgG- Negative.• IgA- Negative.• IgM- Negative.• C3- Mild vascular staining. • C1q- Negative.• Kappa- Negative.• Lambda- Negative.• Fibrin- Mild interstitial staining. • Albumin- Negative.
![Page 17: U01-4411 and U06- 18160](https://reader033.fdocuments.in/reader033/viewer/2022061506/5681451f550346895db1e292/html5/thumbnails/17.jpg)
C3
![Page 18: U01-4411 and U06- 18160](https://reader033.fdocuments.in/reader033/viewer/2022061506/5681451f550346895db1e292/html5/thumbnails/18.jpg)
Fibrin
![Page 19: U01-4411 and U06- 18160](https://reader033.fdocuments.in/reader033/viewer/2022061506/5681451f550346895db1e292/html5/thumbnails/19.jpg)
EM
• Will be ready next week
![Page 20: U01-4411 and U06- 18160](https://reader033.fdocuments.in/reader033/viewer/2022061506/5681451f550346895db1e292/html5/thumbnails/20.jpg)
DiagnosisRenal Biopsy:
• Focal proliferative and necrotizing glomerulonephritis progressing toward end-stage renal disease.
• A previously documented membranous glomerulopathy seen in 2001 is less apparent now.
![Page 21: U01-4411 and U06- 18160](https://reader033.fdocuments.in/reader033/viewer/2022061506/5681451f550346895db1e292/html5/thumbnails/21.jpg)
Comment
• This biopsy appears to show a more advanced stage of the process seen in the previous biopsy in 2001.
• Now the membranous process is less apparent
• The disease process seems to be mainly the focal proliferative and necrotizing GN, which has now progressed to nearly end-stage disease.
![Page 22: U01-4411 and U06- 18160](https://reader033.fdocuments.in/reader033/viewer/2022061506/5681451f550346895db1e292/html5/thumbnails/22.jpg)
Dx: Recurrent ANCA-associated GN Tx: Given recent pneumonia and oral thrush,
hesitant to use cyclophosphamide. Therefore, continued high dose prednisone, started plasmapheresis and Rituximab
Sept 28: sCr(peak)=549Sept 29: plasmapheresis started sCr trending down to low 500s. No HD yet